Pricing Log in Create free account

Gain Therapeutics, Inc. (GANX) vs Pliant Therapeutics, Inc. (PLRX)

Gain Therapeutics, Inc. and Pliant Therapeutics, Inc. are both Biotechnology companies. Gain Therapeutics, Inc. and Pliant Therapeutics, Inc. are of similar size ($60.2M and $58.1M). Gain Therapeutics, Inc. grew revenue faster over the last twelve months: 18.4% against −49.0%. Across the 12 metrics below, Pliant Therapeutics, Inc. leads on 7 and Gain Therapeutics, Inc. on 5.

Valuation

Metric GANX PLRX Biotechnology median
P/E n/m n/m 8.50
P/S 276.65 11.09 9.71
P/B 4.78 0.38 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.76 0.64
EV/Sales 211.41 (14.31) 9.21
Earnings yield (39.68%) (165.56%) (33.15%)
Free cash flow yield (35.12%) (126.73%) (25.50%)

Profitability

Metric GANX PLRX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (268.30%) (50.29%) (56.36%)
Return on assets (159.22%) (37.69%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GANX PLRX Biotechnology median
Revenue growth (TTM) 18.36% (48.95%) 6.02%
EPS growth (last fiscal year) 31.46% 29.97% 30.26%
Revenue growth, 5-year CAGR 21.79% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GANX PLRX Biotechnology median
Debt to equity 0.03 0.00 0.00
Current ratio 4.36 9.90 4.72
Net debt to EBITDA 1.10 1.27 0.96

Dividend

Metric GANX PLRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GANX PLRX Biotechnology median
Market cap 58.05m 60.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack